The U.S. Department of Health and Human Services is on a bold mission to develop a universal flu vaccine within four years, a project that could revolutionize how we combat influenza and prepare for future pandemics. Funded by $500 million, this initiative aims for FDA approval by 2029, with clinical trials starting soon. Experts weigh in on the challenges and potential of this ambitious project.
Peter Marks, the FDA's Center for Biologics Evaluation and Research head, resigns amid growing concerns over measles outbreaks and vaccine misinformation. His exit raises alarms about future public health initiatives.
Long Covid is a devastating reality for millions, with debilitating symptoms and a lack of support. As more people fall ill, the government’s inaction raises urgent questions about care and treatment.
A new coronavirus related to MERS-CoV has been discovered in bats in Brazil, raising concerns about its potential to infect humans. Experiments to assess this risk are set for 2025, as researchers highlight the importance of ongoing viral surveillance.
Discover the intriguing story of Amy Gleason, the newly appointed acting administrator of DOGE with a background in health care technology and ties to the Trump administration. Learn about her work in the federal response to the coronavirus pandemic and advocacy for juvenile myositis patients.
A new coronavirus discovered in bats has sent Asian diagnostic kit makers and vaccine producers’ stocks soaring. Researchers warn of potential animal-to-human transmission.
Chinese researchers uncover a bat coronavirus with similarities to SARS-CoV-2, sparking fears of potential human transmission. Find out more about the study's findings and expert opinions.
